IPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth

Stem Cells and Development

Volumn 23, Issue 15, 2014, Pages 1777-1787

  Doers, Matthew E ^a   Musser, Michael T ^a   Nichol, Robert ^b   Berndt, Erich R ^a   Baker, Mei ^b,c,d   Gomez, Timothy M ^b   Zhang, Su Chun ^a,b   Abbeduto, Leonard ^a,e   Bhattacharyya, Anita ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d Newborn Screening Laboratory   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; FIBROBLAST; FOREBRAIN; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOSAICISM; NERVE FIBER GROWTH; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; CELL LINE; INDUCED PLURIPOTENT STEM CELL; NEURITE; PATHOLOGY; PRESCHOOL CHILD;

CELL DIFFERENTIATION; CELL LINE; CHILD; CHILD, PRESCHOOL; FRAGILE X SYNDROME; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; NEURITES; PROSENCEPHALON;

EID: 84904608102     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0030     Document Type: Article

References (66)

1. Hagerman RJ and PJ Hagerman. (2002). Fragile X Syndrome. Johns Hopkins University Press, Baltimore MD.
2. Hagerman RJ, MY Ono and PJ Hagerman. (2005). Recent advances in fragile X: A model for autism and neurodegeneration. Curr Opin Psychiatry 18:490-496.
3. Coffee B, F Zhang, ST Warren and D Reines. (1999). Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22:98-101.
4. Verkerk AJ, M Pieretti, JS Sutcliffe, YH Fu, DP Kuhl, A Pizzuti, O Reiner, S Richards, MF Victoria and FP Zhang. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
5. Pieretti M, FP Zhang, YH Fu, ST Warren, BA Oostra, CT Caskey and DL Nelson. (1991). Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
6. Verheij C, CE Bakker, E de Graaff, J Keulemans, R Willemsen, AJ Verkerk, H Galjaard, AJ Reuser, AT Hoogeveen and BA Oostra. (1993). Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
7. Coffee B, F Zhang, S Ceman, ST Warren and D Reines. (2002). Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet 71:923-932.
8. Devys D, Y Lutz, N Rouyer, JP Bellocq and JL Mandel. (1993). The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
9. Eberhart DE, HE Malter, Y Feng and ST Warren. (1996). The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5:1083-1091.
10. Feng Y, CA Gutekunst, DE Eberhart, H Yi, ST Warren and SM Hersch. (1997). Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
11. Hinds HL, CT Ashley, JS Sutcliffe, DL Nelson, ST Warren, DE Housman and M Schalling. (1993). Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36-43.
12. Sidorov MS, BD Auerbach and MF Bear. (2013). Fragile X mental retardation protein and synaptic plasticity. Mol brain 6:15.
13. Ashley CT, Jr., KD Wilkinson, D Reines and ST Warren. (1993). FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262:563-566.
14. Brown V, P Jin, S Ceman, JC Darnell, WT O'Donnell, SA Tenenbaum, X Jin, Y Feng, KD Wilkinson, et al. (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487.
15. Miyashiro KY, A Beckel-Mitchener, TP Purk, KG Becker, T Barret, L Liu, S Carbonetto, IJ Weiler, WT Greenough and J Eberwine. (2003). RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37:417-431.
16. Iossifov I, M Ronemus, D Levy, Z Wang, I Hakker, J Rosenbaum, B Yamrom, YH Lee, G Narzisi, et al. (2012). De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-299.
17. Darnell J. (2011). Defects in translational regulation contributing to human cognitive and behavioral disease. Curr Opin Genet Dev 21:465-473.
18. Bolduc FV, K Bell, H Cox, KS Broadie and T Tully. (2008). Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci 11:1143-1145.
19. Dockendorff TC, HS Su, SM McBride, Z Yang, CH Choi, KK Siwicki, A Sehgal and TA Jongens. (2002). Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34:973-984.
20. Grossman AW, NM Elisseou, BC McKinney and WT Greenough. (2006). Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res 1084:158-164.
21. Morales J, PR Hiesinger, AJ Schroeder, K Kume, P Verstreken, FR Jackson, DL Nelson and BA Hassan. (2002). Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34:961-972.
22. Pan L, YQ Zhang, E Woodruff and K Broadie. (2004). The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr Biol 14: 1863-1870.
23. Tucker B, RI Richards and M Lardelli. (2006). Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. Hum Mol Genet 15:3446-3458.
24. Zhang YQ, AM Bailey, HJ Matthies, RB Renden, MA Smith, SD Speese, GM Rubin and K Broadie. (2001). Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107:591-603.
25. Bakker CE and BA Oostra. (2003). Understanding fragile X syndrome: Insights from animal models. Cytogenet Genome Res 100:111-123.
26. Brouwer JR, EJ Mientjes, CE Bakker, IM Nieuwenhuizen, LA Severijnen, HC Van der Linde, DL Nelson, BA Oostra and R Willemsen. (2007). Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated fragile X full mutation. Exp Cell Res 313:244-253.
27. Urbach A, O Bar-Nur, GQ Daley and N Benvenisty. (2010). Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6:407-411.
28. Eiges R, A Urbach, M Malcov, T Frumkin, T Schwartz, A Amit, Y Yaron, A Eden, O Yanuka, N Benvenisty and D Ben Yosef. (2007). Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1:568-577.
29. Sheridan SD, KM Theriault, SA Reis, F Zhou, JM Madison, L Daheron, JF Loring and SJ Haggarty. (2011). Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 6:e26203.
30. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
31. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
32. Zhang SC. (2006). Neural subtype specification from embryonic stem cells. Brain Pathol 16:132-142.
33. Hu BY and SC Zhang. (2010). Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs. Methods Mol Biol 636:123-137.
34. Hu BY, JP Weick, J Yu, LX Ma, XQ Zhang, JA Thomson and SC Zhang. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107:4335-4340.
35. Chambers SM, CA Fasano, EP Papapetrou, M Tomishima, M Sadelain and L Studer. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275-280.
36. Schmittgen TD and KJ Livak. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108.
37. Seltzer MM, MW Baker, J Hong, M Maenner, J Greenberg and D Mandel. (2012). Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet 159B:589-597.
38. Dent EW and KF Meiri. (1992). GAP-43 phosphorylation is dynamically regulated in individual growth cones. J Neurobiol 23:1037-1053.
39. Maenner MJ, MW Baker, KW Broman, J Tian, JK Barnes, A Atkins, E McPherson, J Hong, MH Brilliant and MR Mailick. (2013). FMR1 CGG expansions: Prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet 162B:466-473.
40. Nolin SL, A Glicksman, GE Houck, Jr., WT Brown and CS Dobkin. (1994). Mosaicism in fragile X affected males. Am J Med Genet 51:509-512.
41. Tassone F, A Beilina, C Carosi, S Albertosi, C Bagni, L Li, K Glover, D Bentley and PJ Hagerman. (2007). Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13:555-562.
42. Abitbol M, C Menini, AL Delezoide, T Rhyner, M Vekemans and J Mallet. (1993). Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4:147-153.
43. Liu H and SC Zhang. (2011). Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci 68:3995-4008.
44. Antar LN, C Li, H Zhang, RC Carroll and GJ Bassell. (2006). Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 32:37-48.
45. Bassell GJ and ST Warren. (2008). Fragile X syndrome: Loss of local mRNA regulation alters synaptic development and function. Neuron 60:201-214.
46. Dictenberg JB, SA Swanger, LN Antar, RH Singer and GJ Bassell. (2008). A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 14:926-939.
47. Bhattacharyya A, E McMillan, K Wallace, TC Tubon, Jr., EE Capowski and CN Svendsen. (2008). Normal neurogenesis but abnormal gene expression in human fragile X cortical progenitor cells. Stem Cells Dev 17:107-117.
48. Castren M, T Tervonen, V Karkkainen, S Heinonen, E Castren, K Larsson, CE Bakker, BA Oostra and K Akerman. (2005). Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA 102:17834-17839.
49. Telias M, M Segal and D Ben-Yosef. (2013). Neural differentiation of fragile X human embryonic stem cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol 374:32-45.
50. Park IH, N Arora, H Huo, N Maherali, T Ahfeldt, A Shimamura, MW Lensch, C Cowan, K Hochedlinger and GQ Daley. (2008). Disease-specific induced pluripotent stem cells. Cell 134:877-886.
51. Martins-Taylor K, BS Nisler, SM Taapken, T Compton, L Crandall, KD Montgomery, M Lalande and RH Xu. (2011). Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 29:488-491.
52. Gore A, Z Li, HL Fung, JE Young, S Agarwal, J Antosiewicz-Bourget, I Canto, A Giorgetti, MA Israel, et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-67.
53. Wang T, ST Warren and P Jin. (2013). Toward pluripotency by reprogramming: Mechanisms and application. Protein Cell 4:820-832.
54. McConnell MJ, MR Lindberg, KJ Brennand, JC Piper, T Voet, C Cowing-Zitron, S Shumilina, RS Lasken, JR Vermeesch, IM Hall and FH Gage. (2013). Mosaic copy number variation in human neurons. Science 342:632-637.
55. Kunst CB, EP Leeflang, JC Iber, N Arnheim and ST Warren. (1997). The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing. J Med Genet 34:627-631.
56. Jin P and ST Warren. (2000). Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 9:901-908.
57. Loesch DZ, R Huggins, DA Hay, AK Gedeon, JC Mulley and GR Sutherland. (1993). Genotype-phenotype relationships in fragile X syndrome: A family study. Am J Hum Genet 53:1064-1073.
58. Loesch DZ, RM Huggins and RJ Hagerman. (2004). Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev 10:31-41.
59. Hagerman RJ, CE Hull, JF Safanda, I Carpenter, LW Staley, RA O'Connor, C Seydel, MM Mazzocco, K Snow, SN Thibodeau, et al. (1994). High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298-308.
60. Loesch DZ, S Sherwell, G Kinsella, F Tassone, A Taylor, D Amor, S Sung and A Evans. (2012). Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet 82:88-92.
61. Johnson MA, JP Weick, RA Pearce and SC Zhang. (2007). Functional neural development from human embryonic stem cells: Accelerated synaptic activity via astrocyte coculture. J Neurosci 27:3069-3077.
62. Pankratz MT, XJ Li, TM Lavaute, EA Lyons, X Chen and SC Zhang. (2007). Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25:1511-1520.
63. Shi Y, P Kirwan and FJ Livesey. (2012). Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 7:1836-1846.
64. Wisniewski KE, SM Segan, CM Miezejeski, EA Sersen and RD Rudelli. (1991). The Fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38:476-480.
65. Irwin SA, B Patel, M Idupulapati, JB Harris, RA Crisostomo, BP Larsen, F Kooy, PJ Willems, P Cras, et al. (2001). Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am J Med Genet 98:161-167.
66. Hinton VJ, WT Brown, K Wisniewski and RD Rudelli. (1991). Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289-294.